Terms Sheet - Skin Cancer
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- TG1042 Update - Melanoma
- TG1042 Batch Manufacturing Completed - 26 July 2011
- Suspension from Official Quotation - VHLG
- Rights Offer - 19 July 2011
- Dutchess Continuous Investment Agreement - 10 January 2012
Later from Prescient Therapeutics
- Executive Management Change
- March 2016 Appendix 4C - Quarterly
- PTX Secures $7.0M Capital Raising
- Offer Document
- Replacement Entitlement Offer Prospectus
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics